NCT00001901View on ClinicalTrials.gov

Etanercept to Treat Wegener's Granulomatosis

PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

February 28, 1999

Study Completion Date

March 31, 2005

Conditions

VasculitisWegener's Granulomatosis

Interventions

DRUG

Etanercept

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH